Table 1 Enrollment characteristic of women who had undergone cervical surgery after randomization to HPV-16/18 AS04-adjuvanted vaccine or placebo. * The total percentages of each HPV type is not necessarily equal to 100% because a result may be counted more than once in cases where the participants contained multiple HPV type. ASCUS: atypical squamous cells of undetermined significance; ASCH: atypical squamous cell, but cannot exclude high-grade squamous intraepithelial lesion; AGC: atypical glandular cells; LSIL: low-grade squamous intraepithelial lesion; HSIL: high-grade squamous intraepithelial lesion; Inadequate: unsatisfactory cytological results; HPV: human papillomavirus; HR-HPV: high-risk human papillomavirus; LR-HPV: low-risk human papillomavirus
